Big Molecule Watch

ID: 1b83e026-2619-30fb-68c4

/

Claimed Record

/

Organization: Goodwin Procter

Clinical Updates

Big Molecule Watch · February 8, 2021

Q4 2020 and Full Year Earnings Roundup: Biologics and Biosimilars Update

Big Molecule Watch · February 3, 2021

Health Canada Approves Celltrion’s Infliximab Biosimilar for Treatment of Rheumatoid Arthritis

Big Molecule Watch · February 2, 2021

CHMP adopts positive opinions on two bevacizumab biosimilars

Big Molecule Watch · February 1, 2021

FDA Accepts Bio-Thera Solutions’ Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin®

Big Molecule Watch · January 29, 2021

Practice Areas

Intellectual Property

Jurisdictions